DEUTSCHE BANK AG\ - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 14 filers reported holding PTC THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$3,951,000
+115.7%
4,000,000
+100.0%
0.00%0.0%
Q1 2018$1,832,000
+388.5%
2,000,000
+312.4%
0.00%
Q2 2017$375,000
+77.7%
485,000
+44.3%
0.00%
Q1 2017$211,000
-73.5%
336,000
-74.9%
0.00%
-100.0%
Q4 2016$795,000
-74.2%
1,336,000
-77.0%
0.00%
-50.0%
Q3 2016$3,077,0005,807,0000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 31,204,000$33,828,0001.01%
Opti Capital Management, LP 8,000,000$8,743,0000.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,519,000$16,885,0000.37%
CSS LLC/IL 7,007,000$7,544,0000.31%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 14,527,000$15,558,0000.28%
WOLVERINE ASSET MANAGEMENT LLC 19,454,000$20,896,0000.16%
LMR Partners LLP 9,500,000$10,292,0000.16%
Aequim Alternative Investments LP 2,000,000$2,155,0000.09%
Verition Fund Management LLC 8,091,000$8,718,0000.08%
SG Americas Securities, LLC 61,550$6,632,0000.03%
View complete list of PTC THERAPEUTICS INC shareholders